Curis Lifesciences Merger & Restructuring Worth ₹0.05 Cr

Curis Lifesciences Other Announcement

Curis Lifesciences Limited informed that it is not required to submit a Corporate Governance Report, as its securities are listed on the SME platform.

Curis Lifesciences Annual General Meeting

Curis Lifesciences Limited conducted its 10th Annual General Meeting on September 29, 2026, to transact various agenda items, including financial statement adoption and director appointments.

Curis Lifesciences Annual General Meeting

Curis Lifesciences filed its 10th AGM notice and FY 2025-26 Annual Report. The meeting is scheduled for September 29, 2026.

Curis Lifesciences Board Meeting Outcome

Curis Lifesciences Limited approved the Director's Report, related party transactions, and scheduled its 10th Annual General Meeting for September 29, 2026. Board outcomes were finalized.

Curis Lifesciences Management Change

Curis Lifesciences Limited announced the resignation of Mr. Nikhil Purohit as Company Secretary and Compliance Officer, effective September 3, 2026.

Curis Lifesciences Other Announcement

Curis Lifesciences Limited submitted the RTA confirmation certificate for the quarter ended June 30, 2026, as required under SEBI Regulation 74(5).

Symphony Merger & Restructuring Worth ₹27 Cr

Symphony will sell its Bodakdev vacant land for ₹27 Crore, versus ₹5.68 Crore book value. Sale deed is expected November 6, 2026; operations are unaffected.

Value

₹27.00 Cr

Juniper Green Energy Merger & Restructuring Worth ₹0.15 Cr

Juniper Green Energy incorporated wholly owned subsidiary Juniper Green Beta Fifteen Private Limited on October 30, 2026. The company subscribed to 1,50,000 shares for Rs.0.15 Crore.

Value

₹0.15 Cr

Oricon Enterprises Merger & Restructuring Worth ₹145 Cr

Oricon Enterprises sold its leasehold land and building to Anand Rathi Towers for Rs.145 Crore. The sale is completed and the buyer is unrelated to promoters.

Value

₹145.0 Cr

Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr

Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.

Value

₹0.00 Cr

Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.

Value

₹0.08 Cr

Weagro Merger & Restructuring Worth ₹0.01 Cr

Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.

Value

₹0.01 Cr

Execution

Within two months from the date of the Board decision, subject to statutory approvals.